CTLA-4 expression was associated with longer OS in lymph node-positive patients (OS: HR: 0.53 (0.31–0.92); P=0.021) but not in lymph node-negative patients (HR: 0.51 (0.20–1.29); P=0.14). The gene discussed is CTLA4; the disease is benign neoplasm.